MedPath
TGA Approval

SUGAMMADEX KABI sugammadex (as sodium) 500 mg/5 mL solution for injection vial (405170)

405170

SUGAMMADEX KABI sugammadex (as sodium) 500 mg/5 mL solution for injection vial

Fresenius Kabi Australia Pty Ltd

January 24, 2024

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-01151-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-PI-01150-1

Active Ingredients

sugammadex sodium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SUGAMMADEX KABI sugammadex (as sodium) 500 mg/5 mL solution for injection vial (405170) - TGA 批准文号 | MedPath